Po Wen Wu
Algemeen Directeur bij Polaris Pharmaceuticals, Inc.
Profiel
Po Wen Wu is currently the President & Chief Executive Officer at Polaris Pharmaceuticals, Inc. and the Chairman & Chief Executive Officer at Designerx Pharmaceuticals, Inc. He is also the Chief Executive Officer & Director at DRX USA, DRX Chengdu, and TDW Pharmaceuticals, Inc. Additionally, he serves as a Director at DesigneRx Europe Ltd., DRX SHANGHAI, and DRX Hong Kong.
In the past, he was the President & Chief Executive Officer at Polaris Group, Inc. from 2011 to 2013 and the Chairman & General Manager at Polaris Group.
Dr. Wu holds a doctorate degree from the University of California, Berkeley.
Actieve functies van Po Wen Wu
| Bedrijven | Functie | Begin |
|---|---|---|
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Algemeen Directeur | - |
| DesigneRx Europe Ltd. | Directeur/Bestuurslid | - |
| Designerx Pharmaceuticals, Inc. | Algemeen Directeur | - |
| DRX USA | Algemeen Directeur | - |
| TDW Pharmaceuticals, Inc. | Algemeen Directeur | - |
| DRX Chengdu | Algemeen Directeur | - |
| DRX SHANGHAI | Directeur/Bestuurslid | - |
| DRX Hong Kong | Directeur/Bestuurslid | - |
Eerdere bekende functies van Po Wen Wu
| Bedrijven | Functie | Einde |
|---|---|---|
Polaris Group, Inc.
 Polaris Group, Inc. Real Estate DevelopmentFinance Polaris Group is a sales, marketing and consulting firm with experience in bringing new residential real estate to market in the San Francisco Bay Area and Southern California. Polaris Group has three distinct divisions: Polaris Analytics, Polaris Marketing and Polaris Sales. From land acquisition, market research and entitlements, to architectural review, brand development and escrow coordination, Polaris Group analyzes each new home community and attempts to maximize builder opportunities. Their approach is based on constant evaluation of pricing trends, new product supply pipelines, construction pricing and market conditions. | President | 06-03-2013 |
| ░░░░░░░ ░░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
Opleiding van Po Wen Wu
| University of California, Berkeley | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| POLARIS GROUP | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Polaris Group, Inc.
Polaris Group, Inc. Real Estate DevelopmentFinance Polaris Group is a sales, marketing and consulting firm with experience in bringing new residential real estate to market in the San Francisco Bay Area and Southern California. Polaris Group has three distinct divisions: Polaris Analytics, Polaris Marketing and Polaris Sales. From land acquisition, market research and entitlements, to architectural review, brand development and escrow coordination, Polaris Group analyzes each new home community and attempts to maximize builder opportunities. Their approach is based on constant evaluation of pricing trends, new product supply pipelines, construction pricing and market conditions. | Finance |
Polaris Pharmaceuticals, Inc.
Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
| TDW Pharmaceuticals, Inc. | |
| DesigneRx Europe Ltd. | |
| Designerx Pharmaceuticals, Inc. | |
| DRX USA | |
| DRX Chengdu | |
| DRX SHANGHAI | |
| DRX Hong Kong |